BMC Medical Genomics

official impact factor 3.77

Open Access Research article

Gene expression in BMPR2 mutation carriers with and without evidence of Pulmonary Arterial Hypertension suggests pathways relevant to disease penetrance

James West1*, Joy Cogan2, Mark Geraci4, Linda Robinson1, John Newman1, John A Phillips2, Kirk Lane1, Barbara Meyrick1,3 and Jim Loyd1

Author Affiliations

1 Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA

2 Department of Genetics, Vanderbilt University Medical Center, Nashville, Tennessee, USA

3 Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee, USA

4 Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, Denver, Colorado, USA

For all author emails, please log on.

BMC Medical Genomics 2008, 1:45 doi:10.1186/1755-8794-1-45

Published: 29 September 2008

Additional files

Additional file 1:

Genes Differentially Regulated in Affected vs Unaffected BMPR2 Mutation Carriers. Table, sorted by gene ontology group, of genes differentially regulated between affected and unaffected BMPR2 mutation carriers, including fold changes, absolute values, and associated GO consortium terms.

Format: XLS Size: 54KB Download file

This file can be viewed with: Microsoft Excel Viewer

Open Data

Additional file 2:

GTP-related probes differentially regulated in at least two patients compared to controls. Table, sorted by gene symbol, of Affymetrix probes differentially regulated in at least two affected BMPR2 mutation carriers compared to unaffected. Values that are differentially expressed at least 1.4× with a minimum 150 absolute change are highlighted in yellow; between 2 and 4 of the affected values for each probe will thus be altered.

Format: XLS Size: 30KB Download file

This file can be viewed with: Microsoft Excel Viewer

Open Data